Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges
Advanced therapy medicinal products (ATMPs) are a novel class of medicines with enormous potential to improve treatments for a wide range of diseases, including those affecting eye structures [...]
Enregistré dans:
Auteurs principaux: | Yolanda Diebold, Laura García-Posadas |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5fd46a85d7dc47c7af779ba1d042cf5c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Guest editorial: The ten most important qualities for the profession of medicinal research
par: Tony Y. Zhang
Publié: (2021) -
Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red
par: Kateryna Peleshok, et autres
Publié: (2021) -
Lifting lockdown COVID19 restrictions: What can pharmacists do as the world wakes up?
par: Fatemah Ashkanani, et autres
Publié: (2021) -
Evaluation of Administration Time and Adherence Rates of Morning vs. Bedtime Dosing of Antihypertensive Medications
par: Laura A. Perry, et autres
Publié: (2019) -
An Italian survey of opioids misuse: Epidemiological and psychopathological aspects
par: Gianfranco Stigliano, et autres
Publié: (2021)